Qiagen NV at Citi Healthcare Services, Medtech, Tools, & HCIT Virtual Conference Transcript
Okay. Great. Thank you for joining us. Excited to have Thierry Bernard, the CEO of QIAGEN with us for the next session here at the Citi conference.
I'm Patrick Donnelly, the tools and diagnostics analyst here at Citi. And Thierry, maybe I'll turn it over to you quickly just for a few minute intro, and then we'll dive into questions. If anyone has specific questions, I think there's an area on the screen to ask or feel free to e-mail me and I'll make sure to ask.
But Thierry, maybe I'll turn it over to you for a quick intro.
Okay. Thanks, Patrick, and very pleased to be with you guys. Good afternoon, good morning, depending on where you are in the world, but potentially good evening for some of you here in Asia as well. So in a few words, if you remember, when I was asked to take over at the end of 2019, we came to you to -- with some commitments of increased transparency and focusing on executing quarter after quarter.
I
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |